(*) USA Approval Date: 2017. 06.23
>Betrixaban Cap. (AntiCoagulant)
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 3
Patent>UpDate: 2017. 06.20
TradeMark
TradeMark Web-Site
VTE: Venous ThromboEmbolism